• Home
  • >
  • Sms Lifesciences India Ltd Financials
https://storage.googleapis.com/assets.cdp.blinkx.in/Blinkx_Website/icons/sms-lifesciences-india-ltd.png Logo

Sms Lifesciences India Ltd Financial Statement

Sms Lifesciences India Ltd Income Statement
Quarterly
Annual

*All values are in Rs. Cr

(Rs. CR)Dec 2023Sep 2023Jun 2023
Revenue71.8768.1875.14
Operating Expense62.2158.3769.44
Net Profit3.313.120.7
Net Profit Margin4.614.580.93
Earning Per Share10.9610.312.32
EBIDTA9.49.555.45
Effective Tax Rate15.5314.277.01

(Rs. Cr)

Revenue

Operating Expense

Net Profit

Net Profit Margin

Earning Per Share

EBIDTA

Effective Tax Rate

Sms Lifesciences India Ltd Profit & Loss

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Total Revenue Annual315.56350.07265.59
Operating Expenses Annual286.81315.59235.41
Operating Profit Annual34.1848.9131.96
Interest Annual6.796.174.53
Depreciation10.159.527.35
Net Profit Annual11.4625.3213.56
Tax Annual5.227.436.01

Particulars

Total Revenue Annual

Operating Expenses Annual

Operating Profit Annual

Interest Annual

Depreciation

Net Profit Annual

Tax Annual

Sms Lifesciences India Ltd Cash Flow

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Cash Flow at the Beginning0.998.542.15
Cash Flow from Operations14.7-11.2435.17
Cash Flow from Investing-31.29-7.14-26.23
Cash Flow from Financing16.8910.83-2.55
Cash Flow at the End1.280.998.54

Particulars

Cash Flow at the Beginning

Cash Flow from Operations

Cash Flow from Investing

Cash Flow from Financing

Cash Flow at the End

Sms Lifesciences India Ltd Key Ratios

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
PBDIT Margin (%)8.919.3110.85
PBIT Margin (%)5.896.748.19
PBT Margin (%)5.025.636.36
Net PROFIT Margin (%)3.766.694.59
Return On Networth / Equity (%)6.1211.2611.07
Return On Networth /Employed(%)8.3111.9512.53
Return On Assets (%)4.9611.517.02
Total Debt / Equity(X)0.470.390.4
Asset Turnover Ratio (%)1.321.721.53

Particulars

PBDIT Margin (%)

PBIT Margin (%)

PBT Margin (%)

Net PROFIT Margin (%)

Return On Networth / Equity (%)

Return On Networth / Employed(%)

Return On Assets (%)

Total Debt / Equity(X)

Asset Turnover Ratio (%)

Sms Lifesciences India Ltd Balance Sheet

*All values are in Rs. Cr

Consolidated
Standalone
ParticularsMar 2023Mar 2022Mar 2021
Fixed Assets Annual228.36142.03129.78
Total Current Assets Annual159.12156.02126.29
Non Current Assets Annual235.77200.73176.01
Total Shareholders Funds Annual168.61152.23129.22
Total Assets Annual394.89356.75302.3

Particulars

Fixed Assets Annual

Total Current Assets Annual

Non Current Assets Annual

Total Shareholders Funds Annual

Total Assets Annual

Sms Lifesciences India Ltd Earning Calls
Dec 2023
EPS beaten by 0.00 %

Open Demat Account

50years
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O

Dividend Pages

PE Ratio

Get Your FAQs Right

As of May 20, 2024, Sms Lifesciences India Ltd has a market capitalization of 157.21 Cr. Value Research classifies it as a Micro-Cap company.

No, Sms Lifesciences India Ltd is not debt-free with a debt-to-equity ratio of 0.60.

In FY 2023, Sms Lifesciences India Ltd recorded a total revenue of approximately 315.56 Cr marking a significant milestone in the company's financial performance.

Sms Lifesciences India Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and 0.1% annually, respectively..

Sms Lifesciences India Ltd's current PE ratio is 13.72.

Sms Lifesciences India Ltd's ROCE averaged 10.4% from the FY ending March 2021 to 2023, with a median of 11.3%. It peaked at 12.1% in March 2021, reflecting strong capital efficiency over the period..

Sms Lifesciences India Ltd's latest EBIT is Rs. 23.38 Cr, surpassing the average EBIT of Rs. 28.79 Cr over the 5 years..